Vnitr Lek 2014, 60(1):59-67

International guidelines for management of severe sepsis and septic shock 2012 - comment

Jiří Chvojka, Martin Matějovič*
jednotka intenzivní péče, I. interní klinika LF UK v Plzni a FN Plzeň, přednosta prof. MUDr. Martin Matějovič, Ph.D.
Biomedicínské centrum LF UK v Plzni

Sepsis is one of the leading and grossly under recognized cause of death in the world. If not recognized early and treated promptly, sepsis leads to septic shock, multiorgan failure and death. This article summarizes recently updated international guidelines for management of severe sepsis and septic shock.

Keywords: recommendation; infection; sepsis; septic shock

Received: July 26, 2013; Accepted: October 4, 2013; Published: January 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chvojka J, Matějovič M. International guidelines for management of severe sepsis and septic shock 2012 - comment. Vnitr Lek. 2014;60(1):59-67.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kochanek KD, Murphy SL, Anderson RN et al. Deaths: final data for 2002. Natl Vital Stat Rep 2004; 53(5): 1-115.
    2. Martin GS, Mannino DS, Eaton S et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348(16): 1546-1554. Go to original source... Go to PubMed...
    3. Gaieski DF, Edwards JM, Kallan MJ et al. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 2013; 41(5): 1167-1174. Go to original source... Go to PubMed...
    4. Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001; 29(7): 1303-1310. Go to original source... Go to PubMed...
    5. Kumar A, Kazmi M, Roberts D et al. Duration of shock prior to antimicrobial administration is the critical determinant of survival in human septic shock. Crit Care Med 2004; 32(Suppl): 41. Go to original source...
    6. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345(19): 1368-1377. Go to original source... Go to PubMed...
    7. Dellinger RP, Levy MM, Rhodes A et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39(2): 165-228. Go to original source... Go to PubMed...
    8. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31(4): 1250-1256. Go to original source... Go to PubMed...
    9. Czura CJ. "Merinoff symposium 2010: sepsis" - speaking with one voice. Mol Med 2011; 17(1-2): 2-3. Go to original source... Go to PubMed...
    10. Vincent JL, Opal SM, Marshall JC et al. Sepsis definitions: time for change. Lancet 2013; 381(9868): 774-775. Go to original source... Go to PubMed...
    11. Gao F, Melody T, Daniles DF et al. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 2005; 9(6): 764-770. Go to original source... Go to PubMed...
    12. Levy MM, Dellinger RP, Townsend SR et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36(2): 222-231. Go to original source... Go to PubMed...
    13. Wacharasint P, Nakada TA, Boyd JH et al. Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock 2012; 38(1): 4-10. Go to original source... Go to PubMed...
    14. Puskarich MA, Trzeciak S, Shapiro NI et al. Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock. Resuscitation 2011; 82(10): 1289-1293. Go to original source... Go to PubMed...
    15. Perner A, Haase N, Guttormsen AB et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367(2): 124-134. Go to original source... Go to PubMed...
    16. Myburgh JA, Finfer S, Bellomo R et al. Australian and New Zealand Intensive Care Society Clinical Trials Group: Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367(20): 1901-1911. Go to original source... Go to PubMed...
    17. Shaw AD, Kellum JA. The risk of AKI in patients treated with Intravenous solutions containing hydroxyethyl starch. Clin J Am Soc Nephrol 2013; 8(3): 497-503. Go to original source... Go to PubMed...
    18. Antonelli M, Sandroni C. Hydroxyethyl starch for intravenous volume replacement: more harm than benefit. JAMA 2013; 309(7): 723-724. Go to original source... Go to PubMed...
    19. Patel A, Waheed U, Brett SJ. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 2013; 39(5): 811-822. Go to original source... Go to PubMed...
    20. Haase N, Perner A, Hennings LI et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013; 346: 839. Dostupné z DOI: <http://doi:10.1136/bmj.f839>. Go to original source... Go to PubMed...
    21. Zarychanski R, Abou-Setta AM, Turgeon AF et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013; 309(7): 678-688. Go to original source... Go to PubMed...
    22. KDIGO AKI Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter 2012; 2(Suppl): 1-138.
    23. Yunos NM, Bellomo R, Hegarty C et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308(15): 1566-1572. Go to original source... Go to PubMed...
    24. Shaw AD, Bagshaw SM, Goldstein SL et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; 255(5): 821-829. Go to original source... Go to PubMed...
    25. De Backer D, Biston P, Devriendt J et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362(9): 779-789. Go to original source... Go to PubMed...
    26. De Backer D, Aldecoa C, Njimi H et al. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 2012; 40(3): 725-730. Go to original source... Go to PubMed...
    27. Matejovic M, Träger K, De Backer D. Noradrenaline and the kidney: foe, friend, or both? Intensive Care Med 2005; 31(11): 1476-1478. Go to original source... Go to PubMed...
    28. Marik PE. Surviving sepsis: going beyond the guidelines. Ann Intensive Care 2011; 1(1): 17. Dostupné z DOI: <http://doi:10.1186/2110-5820-1-17>. Go to original source... Go to PubMed...
    29. Hamzaoui O, Georger JF, Monnet X et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care 2010; 14(4): 142. Go to original source... Go to PubMed...
    30. Sprung CL, Annane D, Keh D et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358(2): 111-124. Go to original source... Go to PubMed...
    31. Annane D, Sébille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288(7): 862-871. Go to original source... Go to PubMed...
    32. Shapiro N, Howell MD, Bates DW et al. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 2006; 48(5): 583-590. Go to original source... Go to PubMed...
    33. Weinstein MP, Reller LB, Murphy JR et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983; 5(1): 35-53. Go to original source... Go to PubMed...
    34. Cockerill FR 3rd, Wilson JW, Vetter EA et al. Optimal testing parameters for blood cultures. Clin Infect Dis 2004; 38(12): 1724-1730. Go to original source... Go to PubMed...
    35. Mermel LA, Maki DG. Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med 1993; 119(4): 270-272. Go to original source... Go to PubMed...
    36. Höffken G, Niederman MS. Nosocomial pneumonia: the importace of a de-escalation strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002; 122(6): 2183-2196. Go to original source... Go to PubMed...
    37. Gaieski DF, Mikkelsen ME, Band RA et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010; 38(4): 1045-1053. Go to original source... Go to PubMed...
    38. Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34(6): 1589-1596. Go to original source... Go to PubMed...
    39. Ibrahim EH, Sherman G, Ward S et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118(1): 146-155. Go to original source... Go to PubMed...
    40. Radej J, Matejovic M. Antimicrobial dosing in critically ill patients requiring renal replacement therapy - maximize efficacy and minimize toxicity! Vnitř Lék 2012; 58(6): 427-429. Go to PubMed...
    41. Kumar A, Zarychanski R, Light B et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis. Crit Care Med 2010; 38(9): 1773-1785. Go to original source... Go to PubMed...
    42. Al-Hasan MN, Wilson JW, Lahr BD et al. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother 2009; 53(4): 1386-1394. Go to original source... Go to PubMed...
    43. Martin-Loeches I, Lisboa T, Rodriguez A et al. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 2010; 36(4): 612-620. Go to original source... Go to PubMed...
    44. Li JZ, Winston LG, Moore DH et al. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. Am J Med 2007; 120(9): 783-790. Go to original source... Go to PubMed...
    45. Chastre J, Wolff M, Fagon JY et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290(19): 2588-2598. Go to original source... Go to PubMed...
    46. Hedrick TL, McElearney ST, Smith RL et al. Duration of antibiotic therapy for ventilator-associated pneumonia caused by non-fermentative gram-negative bacilli. Surg Infect (Larchmt) 2007; 8(6): 589-597. Go to original source... Go to PubMed...
    47. Liu C, Bayer A, Cosgrove SE et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52(3): 18-55. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.